Cheng Zhang

12PUBLICATIONS

37CO-AUTHORS

Molecular targetsPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (12)

Sort by Publication Date:

|Jul 15, 2026

Tinengotinib (TT-00420) inhibits tumor growth and overcomes multidrug resistance in gastrointestinal cancers.

|Oct 06, 2025

SPP1 Drives Colorectal Cancer Liver Metastasis and Immunotherapy Resistance by Stimulating CXCL12 Production in Cancer-Associated Fibroblasts.

Shengde Liu, Zizhen Zhang, Zhenghang Wang

|May 15, 2025

Circulating tumor DNA predicts clinical benefits of immune checkpoint blockade in HER2-negative patients with advanced gastric cancer.

Mei He, Congcong Ji, Zhiwei Li

|Apr 10, 2025

Emerging Strategies of Cell and Gene Therapy Targeting Tumor Immune Microenvironment.

Runtian Wang, Xiaorui Duan, Jian Li

|Jun 21, 2023

ANO1-Mediated Inhibition of Cancer Ferroptosis Confers Immunotherapeutic Resistance through Recruiting Cancer-Associated Fibroblasts.

Fangli Jiang, Keren Jia, Yang Chen

|Dec 03, 2022

Targeting HER3 or MEK overcomes acquired Trastuzumab resistance in HER2-positive gastric cancer-derived xenograft.

Mengqi Zhang, Beifang Li, Haiyan Liao

Pageof 2

Frequent Collaborators

Lin Shen

Xiaoyi Chong

Zuhua Chen

Jian Li

Xiaorui Duan

Zhongwu Li

Xiaotian Zhang

Ruoying Yu

Peng Peng

Keren Jia

Frequent Collaborators

Lin Shen

Xiaoyi Chong

Zuhua Chen

Jian Li